Related Experiment Video
Updated: Jan 8, 2026
07:25
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
18.2K
Use of Rituximab in Pediatric Nephrology: A Bibliometric and Visualization Analysis from 2003 to 2024
1Department of Pediatrics, Guangzhou First People's Hospital, Guangdong Medical University, Zhanjiang, Guangdong, China.
Critical Reviews in Eukaryotic Gene Expression
|December 22, 2025
Summary
Bibliometric analysis shows a growing research trend in using Rituximab (RTX) for pediatric kidney diseases. This highlights RTX
Area of Science:
- Pediatric Nephrology
- Immunosuppressive Therapy
- Bibliometric Analysis
Background:
- Rituximab (RTX) is increasingly utilized in treating pediatric renal diseases.
- Understanding the research landscape of RTX in this field is crucial for identifying trends and future directions.
Purpose of the Study:
- To conduct a bibliometric and visualization analysis of RTX in pediatric renal disease treatment.
- To identify research hotspots, key contributors, and emerging trends in this therapeutic area.
Main Methods:
- Literature search of the Web of Science Core Collection.
- Selection of English-language papers and reviews from 2003-2024.
- Bibliometric analysis using VOSviewer, CiteSpace, and Bibliometrix.
Main Results:
- 525 articles published by 2,797 researchers from 54 countries.
- The United States led in publications; Assistance Publique Hopitaux Paris was a leading institution.
- Pediatric Nephrology and The Lancet were prominent journals; nephrotic syndrome was a key research focus.
Conclusions:
- Consistent growth in publications and citations indicates RTX's significant impact on pediatric renal disease treatment.
- This study provides researchers with insights into current research hotspots and future trends.
- Findings underscore the importance and potential of RTX in managing pediatric kidney conditions.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
191
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
191
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
234
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
234
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
225
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
225
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
171
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
171
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
166
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
166
01:06Renal Drug Clearance: Overview
635
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
635